secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2023-03-24T23:59:59+00:00
Accession:  0001683168-23-001754
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma receives Nasdaq deficiency notice for bid price below $1.00
------------------------------------------------------------------------------

- Nasdaq notified SBFM on March 24, 2023, of bid price non-compliance under Rule 5550(a)(2).
- Closing bid price below $1.00 for 30 consecutive trading days triggered the deficiency.
- Company has 180 calendar days until September 20, 2023, to regain compliance.
- To cure, bid price must close at or above $1.00 for at least 10 consecutive business days.
- If not cured, SBFM may qualify for an additional 180-day period if other listing standards are met.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316823001754/0001683168-23-001754-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316823001754/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-001754

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer